Journal of Interventional Cardiac Electrophysiology · 2021 · 66 citations · 15 references
MedicineCardiologyRadiation OncologyCardio-oncologyCardiothoracic SurgeryTreatment PlanningComputed TomographyRadiation TherapyStereotactic RadiosurgeryStereotactic RadiotherapyAdverse Treatment EffectsDose-related Adverse EffectsImplantable Cardioverter DefibrillatorsManagement Of Ventricular TachycardiaPrimary Efficacy EndpointsStereotactic AblationTreatment Adverse EffectsVentricular Tachycardia Ablation
PURPOSE: We present the preliminary results of the STRA-MI-VT Study (NCT04066517), a spontaneous, phase Ib/II study, designed to prospectively test the safety and efficacy of stereotactic body radiotherapy (SBRT) in patientswith advanced cardiac disease and intractable ventricular tachycardia (VT). METHODS: Cardiac computed tomography (CT) integrated by electroanatomical mapping was used for substrate identification and merged with dedicated CT scans for treatment plan preparation. A single 25-Gy radioablation dose was delivered by a LINAC-based volumetric modulated arc therapy technique in a non-invasive matter. The primary safety endpoint was treatment-related adverse effects during acute and long-term follow-up (FU), obtained by regular in-hospital controls and implantable cardioverter defibrillator (ICD) remote monitoring. The primary efficacy endpoint was the reduction at 3 and 6 months of VT episodes and ICD shocks. RESULTS: Seven out of eight patients (men; age, 70 ± 7 years; ejection fraction, 27 ± 11%; 3 ischemic, 4 non-ischemic cardiomyopathies) underwent SBRT. At a median 8-month FU, no treatment-related serious adverse event occurred. Three patients died from non-SBRT-related causes. Four patients completed the 6-month FU: the number of VT decreased from 29 ± 33 to 11 ± 9 (p = .05) and 2 ± 2 (p = .08), at 3 and 6 months, respectively; shocks decreased from 11 to 0 and 2, respectively. At 6 months, all patients. showed a significant reduction of VT episodes and no electrical storm recurrence, with the complete regression of iterative VTs in 2/2 patients. CONCLUSION: The STRA-MI-VT Study suggests that SBRT can be considered an alternative option for the treatment of VT in patients with structural heart disease and highlights the need for further clinical investigation addressing safety and efficacy.
15
Ventricular Tachycardia Ablation versus Escalation of Antiarrhythmic Drugs
John L. Sapp, George A. Wells, Ratika Parkash et al. · New England Journal of Medicine · 2016 · 842 citations · Full text
Karl‐Heinz Kück, Anselm Schaumann, Lars Eckardt et al. · The Lancet · 2010 · 796 citations
Roderick Tung, Marmar Vaseghi, David S. Frankel et al. · Heart Rhythm · 2015 · 497 citations · Full text